SLG
66
4
RL
72
3
AAP
30
3
KHC
20
2
JBHT
63
3
VMC
62
5
DFS
60
4
ROP
53
2
AKAM
54
3
BDX
41
3
BF.B
31
2
STT
64
4
IVZ
52
6
XYL
35
4
IR
61
6
KEY
34
3
VZ
37
3
ROST
57
3
ITW
64
2
GWW
67
3
SLG
66
4
RL
72
3
AAP
30
3
KHC
20
2
JBHT
63
3
VMC
62
5
DFS
60
4
ROP
53
2
AKAM
54
3
BDX
41
3
BF.B
31
2
STT
64
4
IVZ
52
6
XYL
35
4
IR
61
6
KEY
34
3
VZ
37
3
ROST
57
3
ITW
64
2
GWW
67
3
Financhill
Back

Protagonist Therapeutics Vs. DXP Enterprises Industry Stock Comparison

Sell
44

PTGX
Protagonist Therapeutics

Last Price:
47.60
Seasonality Move:
18.58%
Buy
65

DXPE
DXP Enterprises

Last Price:
65.85
Seasonality Move:
39.89%
Sell
44
Protagonist Therapeutics (PTGX) is a Sell

Is Protagonist Therapeutics a Buy, Sell or Hold?

  • The current Protagonist Therapeutics [PTGX] share price is $45.90. The Score for PTGX is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • PTGX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
65
DXP Enterprises (DXPE) is a Buy

Is DXP Enterprises a Buy, Sell or Hold?

  • The current DXP Enterprises [DXPE] share price is $61.59. The Score for DXPE is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
  • DXPE is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

PTGX Stock Price Chart

What is Protagonist Therapeutics's stock price today?

  • The Protagonist Therapeutics share price today is $45.90
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTGX is experiencing slight buying pressure.

DXPE Stock Price Chart

What is DXP Enterprises's stock price today?

  • The DXP Enterprises share price today is $61.59
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DXPE is experiencing buying pressure, which is a positive indicator for future bullish movement.

PTGX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.55 Buy
Relative Strength Index (14 RSI): 48.74 Sell
Chaikin Money Flow: 154951 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (44.55 - 47.39) Sell
Bollinger Bands (100): (35.98 - 45.9) Buy

DXPE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.37 Buy
Relative Strength Index (14 RSI): 75.92 Buy
Chaikin Money Flow: 171896 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49 - 54.5) Buy
Bollinger Bands (100): (47.11 - 53.29) Buy

PTGX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 47.09 Sell
20-day SMA: 46.37 Sell
50-day SMA: 45.14 Buy
200-day SMA: 34.63 Buy
8-day EMA: 46.69 Sell
20-day EMA: 46.38 Sell
50-day EMA: 44.64 Buy
200-day EMA: 35.99 Buy

DXPE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 51.15 Buy
20-day SMA: 51.64 Buy
50-day SMA: 51.78 Buy
200-day SMA: 47.83 Buy
8-day EMA: 52.64 Buy
20-day EMA: 51.7 Buy
50-day EMA: 51.38 Buy
200-day EMA: 47.37 Buy

Protagonist Therapeutics Earnings Growth & PTGX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.98 per share, and a decrease next year of $3.62 per share.

DXP Enterprises Earnings Growth & DXPE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.24 per share, and an increase next year of $0.30 per share.

Protagonist Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

DXP Enterprises Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):